Epilepsy and other seizure disorders Flashcards

1
Q

Choosing an antiepileptic drug depends on

A

several factors, and the seizure type should determine the choice of treatment.

  • A single antiepileptic drug should be prescribed wherever possible
  • Most antileptics can be given twice daily and the dose should be kept as low as possible to encourage adherence.
  • If treatment with one drug fails it should be stopped and another drug should be tried alone. The first drug should slowly be withdrawn only when the new regimen has been established.
  • Combination therapy with 2 or more drugs may be necessary, but this increases the risk of interactions and side effects.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MHRA Advice: 3 risk-based categories of antiepileptic drugs: category 1

A
  1. Category 1: Phenytoin, Carbamazepine, Phenobarbital + Primidone. Patient should be maintained on a specific manufacturer’s product (specific brand).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Antiepileptic hypersensitivity syndrome

A

If after a few weeks the patient develops a rash, fever and lymphadenopathy this is indicative of antiepileptic hypersensitivity syndrome –> THE DRUG SHOULD BE STOPPED IMMEDIATELY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Withdrawal

A
  • Avoid abrupt withdrawal because this can cause severe rebound seizures.
  • The dose should be reduced gradually, and in the case of barbiturates withdrawal of the drug may take months.
  • Even in patients who have been seizure-free for several years, there is a significant risk of seizure-recurrence on drug withdrawal.
  • In patients receiving several anti-epileptic drugs, only one drug should be withdrawn at a time.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Driving

A

 If a driver has a seizure (of any type) they must stop driving immediately and inform the DVLA.
 To continue driving, the patient must be seizure-free for atleast 1 year.
 Patients who have had a seizure while asleep cannot drive for 1 year from the date of each seizure unless:
- The seizures occur only ever while asleep or
- A pattern of PURELY ASLEEP SEIZURES can be demonstrated over the course of 3 years IF the patient has previously had seizures whilst awake (or awake and asleep).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pregnancy

A
  • There is an increased risk of TERATOGENICITY associated with using antiepileptic drugs. The risk is highest for Valproate.
  • It may be in the best interest of the fetus to withhold antiepileptics during the first trimester.
  • Women of child-bearing potential who take anti-epileptic drugs should be given advice about the need for effective contraception to avoid unplanned pregnancy.
  • If treatment with antiepileptic drugs must continue throughout pregnancy, then MONOTHERAPY is preferable at the lowest effective dose.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

To reduce the risk of neural tube defects

A

• To reduce the risk of neural tube defects (defects of the brain, spine or spinal cord), folate supplementation is advised before conception and throughout the first trimester.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Breastfeeding

A

Women taking anti-epileptic monotherapy should be encouraged to breastfeed. All infants should be monitored for sedation, feeding difficulties, adequate weight gain and developmental milestones.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Types of seizures

A
  • Focal = localised to one hemisphere of the brain
  • Tonic-clonic = Tonic (body is rigid), Clonic (uncontrolled jerking)
  • Myoclonic = shock-like jerks of muscles,
  • Absence = spells of STARING.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

first-line & 2nd line options for focal seizures

A

Carbamazepine and Lamotrigine;

2 line: Levetiracetam, oxcarbazepine, sodium valproate (consider treatment with phenytoin as adjunctive is poor control)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

first-line & 2nd line treatment for tonic-clonic

A

Sodium Valproate;

2nd line: Lamotrigine
3rd line: if both contra, carbamazepine, oxcarbazepine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

first-line & 2nd line options of absence seizures

A

Ethosuximide or Sodium Valproate.

2nd line: lamotrigine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dravet syndrome:

A

Sodium valproate or topiramate are first line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Lennox-Gastaut syndrome:

A

Sodium valproate is first line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Atonic and tonic seizures:

A

Usually seen in childhood, sodium valproate is first line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Carbamazepine advice

A

 It is essential to initiate this drug at a low dose and build it up slowly.
 It may exacerbate tonic, atonic, myoclonic and absence seizures so should be avoided if these seizures are present.
 Patients should be told how to recognise signs of blood, liver and skin disorders: fever, rash, mouth ulcers, bleeding or bruising. In this case: the drug should be WITHDRAWN IMMEDIATELY.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Gabapentin and Pregabalin

A

 Gabapentin and Pregabalin are used for the treatment of focal seizures. They are not recommended if tonic, atonic, absence or myoclonic seizures are present.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

 Gabapentin safety information:

A

the levels of propylene glycol, acesulfame K and saccharin sodium may exceed the recommended WHO daily intake limits if high doses of gabapentin oral solution (ROSEMONT BRAND) are given to adolescents or adults with a low body weight (39-50kg)

  • risk of severe resp. depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Lamotrigine

A
  • Lamotrigine can be used for focal, tonic-clonic, absence and as an adjunctive in atonic or tonic seizures.
  • Myoclonic seizures may be exacerbated by Lamotrigine
  • Valproate increases plasma-lamotrigine concentration whereas enzyme-inducing epileptics reduce it.
20
Q

Lamotrigine SE

A

Skin reactions … Severe skin reactions including SJ syndrome and toxic epidermal necrolysis have developed especially in children, most rashes occur within the first 8 weeks. Consider withdrawal if rash or signs of hypersensitivity syndrome develop. Factors associated with increased risk of serious skin reactions include concomitant use of valproate, initial lamotrigine high dosing and more rapid dose escalation. Look out for signs of bone marrow failure: anaemia, bruising or infection.

21
Q

Phenytoin

A

• Phenytoin is licensed for tonic-clonic and focal seizures but may exacerbate absence or myoclonic seizures.
• It has a NARROW THERAPEUTIC WINDOW and small dosage increases may produce LARGE increases in plasma concentration with acute toxic side-effects (Non-linear dose-plasma relationship).
- Similarly, a few missed doses or small change in drug absorption may result in a marked change in plasma-drug concentration. Thus, plasma-drug concentration should be monitored.

22
Q

Phenytoin SE

A
  1. Rash: discontinue, if mild then re-introduce cautiously but discontinue immediately if recurrence
  2. Bradycardia & hypotension: With IV: reduce rate of administration if bradycardia or hypotension occur
  3. Overdose: symptoms of phenytoin toxicity include nystagmus, diplopia, slurred speech, ataxia, confusion and hyperglycaemia
  • Blood or skin disorders: if fever, rash, mouth ulcers, bruising or bleeding seek medical attention urgent
  • change in appearance (coarsening of hair)
  • low vitamin D
  • hepatotoxicity
  • suicidal thoughts
23
Q

Topiramate SE

A

 This drug can be given alone or as an adjunctive treatment in generalised tonic-clonic or focal seizures.
 Side effects: Acute myopia (close objects look clear but distant objects are blurry) with secondary angle-closure glaucoma typically occurring within 1 month of starting treatment. If raised intraocular pressure occurs, seek ophthalmological advice + stop topiramate as rapidly as feasible.

24
Q

Sodium Valproate cautions

A

 It is the drug of choice for many types of seizures. Take with or just after food unless e/c tablet.
 Cautions: Liver dysfunction can occur when taking Valproate usually in the first 6 months, so liver function must be monitored. Raised liver enzymes during Valproate therapy are temporary but liver function must be monitored until return to normal – discontinue if abnormally long prothrombin time
- pancreatitis (abdominal pain, nausea, vomit)
 Withdraw if persistent vomiting and abdominal pain, anorexia, jaundice, oedema, malaise, drowsiness or loss of seizure control. Discontinue treatment is symptoms of pancreatitis develop (abdominal pain, nausea or vomiting). Advise patients how to recognise symptoms of blood or liver disorders.
 It should not be used in women and girls of child-bearing potential unless alternatives are ineffective/not tolerated due to its high teratogenic potential.
 Gives false-positive urine tests for ketones

25
Q

Benzodiazepines

A

 Clobazam can be prescribed as an adjunctive for tonic-clonic + focal seizures.
 Clonazepam can be prescribed for refractory absence and myoclonic seizures, but it has sedative s.e’s.
 Regardless, all benzodiazepines must be prescribed by or under experienced personnel.

26
Q

Vigabatrin SE & Cautions

A

 Used as an adjunctive for focal seizures (may worsen absence, myoclonic, tonic and atonic seizures)
 Side effects: Encephalopathic symptoms (marked sedation, stupor, confusion with non-specific slow wave ECG – reduce dose or withdraw.
 Cautions: Vigabatrin is associated with visual field defects. The onset of symptoms varies from 1 month to several years after staring. Product literature advises visual field testing before treatment and at 6-month intervals. Patients should be warned to report any new visual symptoms that develop.

27
Q

Fosphenytoin SE

A

 Pro-drug of phenytoin available as IV infusion only
 Side effects: Severe cardiovascular reactions including asystole, ventricular fibrillation + cardiac arrest. Hypotension, bradycardia and heart block have been reported. Thus, monitor heart rate, BP and respiratory function during infusion… observe patient for 30mins after and if hypotension occurs then reduce infusion rate or discontinue. Reduce dose of infusion rate in elderly and in renal or hepatic

28
Q

Status epilepticus (epileptic fits follow one after another without recovery of consciousness)

A
  • Immediate measures to manage status epilepticus include positioning the patient to avoid injury, supporting respiration including provision of oxygen, maintaining blood pressure and the correction of any hypoglycaemia.
  • Seizures lasting longer than 5 minutes should be treated with I.V. Lorazepam (repeated once after 10 minutes if seizures recur or fail to respond). Patients should be monitored for respiratory depression and hypotension.
  • If after treatment with benzodiazepines, seizures recur or fail to respond 25 minutes after onset, phenytoin sodium, fosphenytoin sodium or phenobarbital sodium should be used (by I.V. injection).
  • If these measures fail to control seizures 45 minutes after onset, anaesthesia with thiopental sodium, midazolam or a non-barbiturate anaesthetic should be used
29
Q

MHRA Advice: 3 risk-based categories of antiepileptic drugs: category 2

A
  1. Category 2: Valproate, Lamotrigine, Clonazepam, Clobazam, Topiramate. The need for a specific manufacturer’s product (specific brand) is based on the clinical judgement of the HCP considering seizure frequency and treatment history.
30
Q

MHRA Advice: 3 risk-based categories of antiepileptic drugs: category 3

A
  1. Category 3: Levetiracetam, Gabapentin, Pregabalin, Vigabatrin. Unnecessary to maintain on specific brand
31
Q

plasma conc. changes in pregnancy - which drugs?

A

Phenytoin, Carbamazepine, Lamotrogine

32
Q

monitor foetal growth

A

topiramate/levetiracetam

33
Q

breastfeeding monitor

A

drowsiness, weight gain, feeding difficulty, adverse effect, developmental milestones

34
Q

which drugs are present in high amounts in milk

A

zonisamide, ethosuximide, lamotrigine, primidone

35
Q

which drugs accumulate due to slower metabolism in baby

A

phenobarbital, lamotrigine

36
Q

which drugs are associated with antiepileptic hypersensitivity syndrome

A

rash, fever, lymphadenopathy, systemic involvement

  • Phenytoin, Carbamazepine, Lamotrigine, phenobarbital, primidone
37
Q

which drugs are associated with skin rashes

A

Lamotrigine

38
Q

which drugs are associated with blood dyscrasias

A

Phenytoin, Carbamazepine, Lamotrigine, zonisamide, ethosuximide, valproate, topiramate

39
Q

which drugs are associated with eye problems

A
  • vigabatrin (The onset of symptoms varies from 1 month to several years after starting. Visual problems usually
    persist despite discontinuation, and further deterioration cannot be excluded. Visual field testing before treatment and at 6-month intervals is advised. Any new visual symptoms that develop should be reported and reviewed urgently by an ophthalmologist. Gradual withdrawal of vigabatrin should be considered.)
  • topiramate (acute myopia with secondary angle closure glaucoma, also choroidal effusions and anterior displacement of lens and iris)
40
Q

which drugs are associated with encephalopathic symptoms

A

vigabatrin (marked sedation, stupor, confusion)

41
Q

phenytoin interactions

A

• Increased plasma concentrations with amiodarone, chloramphenicol, cimetidine, diltiazem, fluconazole, fluoxetine,
miconazole, topiramate,
metronidazole, clarithromycin, (enzyme inhibitor) trimethoprim

• Reduced plasma concentrations with rifamycins,
st Johns Wort, (enzyme inducer) theophylline, itraconazole, ciclosporin

  • Anticonvulsant effect antagonised: quinolones, tramadol, mefloquine, SSRI, antipsychotics, TCA
  • Increased antifolate effect (increased risk of blood dyscrasias): MTX, trimethoprim
  • phenytoin (enzyme inducer) reduces drug conc. of: warfarin, hormonal contraceptives/HRT, levothyroxine, liothyronine
42
Q

Carbamazepine interactions

A

• Increased plasma concentration with acetazolamide, cimetidine, clarithromycin, erythromycin, fluoxetine, miconazole (enzyme inhibitors)

• Decreased plasma concentration with phenytoin,
rifabutin, St. John’s Wort (enzyme inducer)

  • Carbamazepine reduces plasma concentration of antipsychotics, corticosteroids, coumarins, eplerenone, warfarin, hormonal contraceptives/HRT, simvastatin
  • Anticonvulsant effect antagonised: quinolones, , mefloquine, SSRI, antipsychotics, TCA
  • risk of hyponatremia: aldosterone antagonists, SSRI, TCA, diuretics, NSAIDs
  • risk of hepatotoxicity: tetracyclines, sulfasalazine, valproate, MTX, isoniazid, statins, fluconazole, alcohol.
43
Q

first-line & 2nd line treatment for myoclonic seizures

A

1st line: Sodium valproate (except in females)

2nd line: Levetiracetam or Topiramate

44
Q

Status Epileptics

A

O2, BP, hypoglycemia controlled.

0-5 min -> Benzodiazepine (lorazepam) IV and repeated once after 10mins.

10-30 min -> Phenytoin/fosphenytoin/phenobarbital (can be given by slow IV; IM or suppository too slow)

30-60 min -> General anaesthesia (Thiopental, midazolam)

NB: If alcohol induced give thiamine.
If pyridoxine deficiency induced give pyridoxine.

45
Q

valproate interactions

A
  • valproate (enzyme inhibitor) increases plasma concentration of other antiepileptics
  • Anticonvulsant effect antagonised: quinolones, , mefloquine, SSRI, antipsychotics, TCA
  • risk of hyponatremia: aldosterone antagonists, SSRI, TCA, diuretics, NSAIDs
  • risk of hepatotoxicity: tetracyclines, sulfasalazine, carbamazepine, MTX, isoniazid, statins, fluconazole, itraconazole
46
Q

medical seizure emergency in community:

A

convulsive seizures or febrile seizures >5 mins:

diazepam rectal or oromucosal midazolam

repeat once after 10-15 mins if necessary